540737
vs
B
BSE Sensex 30
540737
Over the past 12 months, SGRL has underperformed BSE Sensex 30, delivering a return of -30% compared to the BSE Sensex 30's +0% growth.
Stocks Performance
540737 vs BSE Sensex 30
Performance Gap
540737 vs BSE Sensex 30
Performance By Year
540737 vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Shree Ganesh Remedies Ltd
Glance View
Shree Ganesh Remedies Ltd. engages in the research, development, manufacture, and marketing of healthcare products. The company is headquartered in Ankleshwar, Gujarat. The company went IPO on 2017-10-13. The firm is a supplier of pharmaceutical intermediates and specialty chemicals with chlorination, grignard reaction, hydrogenation and high-vacuum distillation. Its products include intermediates by active pharmaceutical ingredient (API), and fine and specialty chemicals. The company offers services, including customized chemistry and manufacturing, assets and infrastructure and key technologies and expertise. The company also delivers service of contract manufacturing for chemical reactions like amination, amidation, alkylation, bromination, catalytic hydrogenation and chlorination. The firm's subsidiaries include Akshar Jyot Private Limited and Dhari Chemicals Limited.
